Pharmacokinetic Changes in Critical Illness - 19/08/11
Doi : 10.1016/j.ccc.2006.02.011
Bradley A. Boucher, PharmD, BCPS a, b, ⁎ 
, G. Christopher Wood, PharmD, BCPS a, Joseph M. Swanson, PharmD, BCPS a
, G. Christopher Wood, PharmD, BCPS a, Joseph M. Swanson, PharmD, BCPS a a Department of Pharmacy, University of Tennessee Health Science Center, 26 South Dunlap, Room 210, Memphis, TN 38163, USA
b Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, TN 38163, USA
⁎Corresponding author. Department of Pharmacy, University of Tennessee Health Science Center, 26 South Dunlap, Room 210, Memphis, TN 38163
Riassunto |
Physiologic alterations in critically ill patients can significantly affect the pharmacokinetics of drugs used in the critically ill patient population. Understanding these pharmacokinetic changes is essential relative to optimizing drug therapy. This article outlines the major differences seen in the absorption, distribution, metabolism, and excretion of drugs in critically ill patients. Important strategies for drug therapy dosing and monitoring in these patients are also addressed.
Il testo completo di questo articolo è disponibile in PDF.Mappa
© 2006
Elsevier Inc. Tutti i diritti riservati.
Vol 22 - N° 2
P. 255-271 - aprile 2006 Ritorno al numero
Articolo precedente
- Corticosteroid Replacement in Critically Ill Patients
- Judith Jacobi
- Principles and Practices of Medication Safety in the ICU
- Sandra Kane-Gill, Robert J. Weber
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?